Insider · CIK 0001532620

BORST STEVEN JOHN

Reports to the SEC for 1 company · SALT LAKE CITY, UT

sec.gov

Transactions

Companies

Filings

CIK

0001532620

Forms 4 and 5

Insider transactions

32 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2015-12-31	Q Therapeutics, Inc.G Gift	Director, Chief Executive Officer	GGift	+10.5K sh	—	—	511,806
2015-09-09	Q Therapeutics, Inc.Option to Purchase Common StockA Award	Director, Chief Executive Officer	AAward	+400K sh	$0.70	+$280K	2,750,274
2015-09-09	Q Therapeutics, Inc.Option to Purchase Common StockA Award	Director, Chief Executive Officer	AAward	+100K sh	$0.70	+$70K	2,850,274
2015-09-09	Q Therapeutics, Inc.Option to Purchase Common StockA Award	Director, Chief Executive Officer	AAward	+100K sh	$0.70	+$70K	2,950,274
2015-09-09	Q Therapeutics, Inc.Option to Purchase Common StockA Award	Director, Chief Executive Officer	AAward	+400K sh	$0.70	+$280K	2,536,674
2015-09-09	Q Therapeutics, Inc.Option to Purchase Common StockA Award	Director, Chief Executive Officer	AAward	+100K sh	$0.70	+$70K	2,636,674
2015-09-09	Q Therapeutics, Inc.Option to Purchase Common StockA Award	Director, Chief Executive Officer	AAward	+100K sh	$0.70	+$70K	2,736,674
2014-12-18	Q Therapeutics, Inc.Option to Purchase Common StockA Award	Director, Chief Executive Officer	AAward	+250K sh	$0.70	+$175K	2,136,674
2014-12-18	Q Therapeutics, Inc.Option to Purchase Common StockA Award	Director, Chief Executive Officer	AAward	+214K sh	$0.70	+$150K	2,350,274
2014-03-11	Q Therapeutics, Inc.Option to Purchase Common StockA Award	Director, Chief Executive Officer	AAward	+200K sh	$0.70	+$140K	1,886,674
2014-03-11	Q Therapeutics, Inc.Option to Purchase Common StockA Award	Director, Chief Executive Officer	AAward	+250K sh	$0.70	+$175K	1,886,674
2014-03-11	Q Therapeutics, Inc.Option to Purchase Common StockA Award	Director, Chief Executive Officer	AAward	+102K sh	$0.70	+$71.4K	1,886,674
2014-03-11	Q Therapeutics, Inc.Option to Purchase Common StockA Award	Director, Chief Executive Officer	AAward	+250K sh	$0.70	+$175K	1,886,674
2012-12-14	Q Therapeutics, Inc.J Other	Director, Chief Executive Officer	JOther	−56.9K sh	—	—	495,871
2012-06-25	Q Therapeutics, Inc.G Gift	Director, Chief Executive Officer	GGift	−10.2K sh	$1.00	−$10.2K	495,871
2012-06-25	Q Therapeutics, Inc.G Gift	Director, Chief Executive Officer	GGift	+5,435 sh	$1.00	+$5,435	495,871
2012-06-25	Q Therapeutics, Inc.Warrants to Purchase Common StockG Gift	Director, Chief Executive Officer	GGift	−10K sh	$1.00	−$10K	1,084,672
2012-06-25	Q Therapeutics, Inc.Warrants to Purchase Common StockG Gift	Director, Chief Executive Officer	GGift	+5,250 sh	$1.00	+$5,250	1,084,672
2012-06-25	Q Therapeutics, Inc.Warrants to Purchase Common StockG Gift	Director, Chief Executive Officer	GGift	−10.2K sh	$1.00	−$10.2K	1,084,672
2012-06-25	Q Therapeutics, Inc.Warrants to Purchase Common StockG Gift	Director, Chief Executive Officer	GGift	+10.2K sh	$1.00	+$10.2K	1,084,672
2012-06-25	Q Therapeutics, Inc.Warrants to Purchase Common StockG Gift	Director, Chief Executive Officer	GGift	−10.2K sh	$2.00	−$20.4K	1,084,672
2012-06-25	Q Therapeutics, Inc.Warramts to Purchase Common StockG Gift	Director, Chief Executive Officer	GGift	+10.2K sh	$2.00	+$20.4K	1,084,672
2012-03-28	Q Therapeutics, Inc.Options to Purchase Common StockA Award	Director, Chief Executive Officer	AAward	+250K sh	$1.00	+$250K	1,084,672
2011-10-13	Q Therapeutics, Inc.A Award	Director, Chief Executive Officer	AAward	+563K sh	—	—	562,970
2011-10-13	Q Therapeutics, Inc.Options to Purchase Common StockA Award	Director, Chief Executive Officer	AAward	+18.9K sh	—	—	18,930
2011-10-13	Q Therapeutics, Inc.Options to Purchase Common StockA Award	Director, Chief Executive Officer	AAward	+173K sh	—	—	173,071
2011-10-13	Q Therapeutics, Inc.Options to Purchase Common StockA Award	Director, Chief Executive Officer	AAward	+210K sh	—	—	209,995
2011-10-13	Q Therapeutics, Inc.Options to Purchase Common StockA Award	Director, Chief Executive Officer	AAward	+150K sh	—	—	150,235
2011-10-13	Q Therapeutics, Inc.Options to Purchase Common StockA Award	Director, Chief Executive Officer	AAward	+210K sh	—	—	210,329
2011-10-13	Q Therapeutics, Inc.Warrants to Purchase Common StockA Award	Director, Chief Executive Officer	AAward	+10K sh	—	—	10,000
2011-10-13	Q Therapeutics, Inc.Warrants to Purchase Common StockA Award	Director, Chief Executive Officer	AAward	+10.2K sh	—	—	10,185
2011-10-13	Q Therapeutics, Inc.Warrants to Purchase Common StockA Award	Director, Chief Executive Officer	AAward	+10.2K sh	—	—	10,185

Recent filings

Accepted (ET)
Feb 124/A
Q Therapeutics, Inc.0001209191-16-098143
SEC(opens sec.gov)
Feb 125
Q Therapeutics, Inc.0001209191-16-098169
SEC(opens sec.gov)
Sep 114
Q Therapeutics, Inc.0001209191-15-070308
SEC(opens sec.gov)
Dec 224
Q Therapeutics, Inc.0001209191-14-077320
SEC(opens sec.gov)
Mar 134
Q Therapeutics, Inc.0001209191-14-020502
SEC(opens sec.gov)
Aug 135
Q Therapeutics, Inc.0001209191-13-040376
SEC(opens sec.gov)

Companies

Q Therapeutics, Inc.Director, Chief Executive Officer

Address

C/O Q THERAPEUTICS, INC. 615 ARAPEEN DRIVE, SUITE 102

SALT LAKE CITY, UT, 84108